Actively Recruiting

Age: 18Years +
All Genders
ID07362043

Assessment of a Hand-held Femtosecond Laser to Perform Anterior Capsulorhexis During Cataract Surgery (Post-market Study)

Led by Helix Surgical · Updated on 2026-01-30

446

Participants Needed

1

Research Sites

8 weeks

Total Duration

On this page

Sponsors

H

Helix Surgical

Lead Sponsor

S

Santé Atlantique - Saint-Herblain - France

Collaborating Sponsor

AI-Summary

What this Trial Is About

Researchers are evaluating the rate of capsular ruptures during cataract surgery using a handheld femtosecond laser called Rx. This observational study aims to confirm if the rupture rate with Rx use is lower than 2%, supplementing data collected in a previous pre-market investigation. The study is conducted at a single center and follows patients prospectively for about 30 days after surgery. The study includes one group of patients undergoing cataract surgery with the Rx laser used as intended. The device is designed to assist in performing the anterior capsulotomy during surgery. The study uses a sequential design with up to 446 patients to monitor the rate of capsule ruptures. Interim analyses determine if the rupture rate meets success or failure criteria, potentially stopping the study early if clear results are found. Participants will have their medical records reviewed and will be followed for approximately 30 days after surgery to assess outcomes. Researchers will monitor the rate of capsule ruptures during surgery, the continuity of the capsulorhexis, and any adverse device effects immediately during surgery and at about 4 days and 30 days post-surgery. This study helps evaluate the safety of using the Rx laser in routine cataract surgery.

CONDITIONS

Brief Title

Assessment of a Hand-held Femtosecond Laser to Perform Anterior Capsulorhexis During Cataract Surgery (Post-market Study)

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Adult patients (age > 18 years)
  • Diagnosed with cataract requiring surgery according to current guidelines
  • Eligible for lens removal by phacoemulsification and replacement by a prosthetic lens under local anesthesia
  • Confirmed their non-opposition to data collection
Not Eligible

You will not qualify if you...

  • Patient already operated with Rx for the first eye
  • Any contra-indication to cataract surgery
  • Anterior Chamber Depth less than 1.8mm or greater than 4.2mm
  • Corneal disease or pathology preventing corneal applanation or interfering with laser beam transmission
  • Presence of blood or other elements hindering light propagation between epithelium and lens
  • Weak pupil dilation or severely off-center pupil preventing adequate iris retraction (dilations < 6.5mm)
  • Abnormal tilt of the lens (> 7 degrees)
  • Significant preoperative ocular hypotonia or hypertonia
  • Presence of an intra-corneal implant
  • Active or unstabilized ocular surface disease including abnormal corneas
  • History of lens disease or zonular instability
  • Any perforating incision of the eyeball causing leakage during corneal applanation
  • Presence of a limbal tumor obstacle hindering device stabilization
  • Patients under guardianship, trusteeship, or deprived of liberty
  • Patients unable to give non-opposition for data collection due to psychiatric, cognitive, or linguistic reasons

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Surgery and Immediate Post-operative Care

Duration - 1 day

Participants undergo cataract surgery using a handheld femtosecond laser for anterior capsulotomy. Device performance and safety are assessed during surgery and shortly after.

1 surgical visit (in-person) and 1 post-operative visit within 4 ± 2 days

Post-operative Follow-up

Duration - Approximately 30 days

Participants are followed for safety and device effects for approximately 30 ± 15 days after surgery.

1 follow-up visit approximately 30 ± 15 days after surgery

Trial Site Locations

Total: 1 location

1

Santé Atlantique

Saint-Herblain, France

Actively Recruiting

Loading map...

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

0

Similar Trials

Pain, Anxiety and Anesthetic Satisfaction for Patients With ...

Oral Anxiolytic

Actively Recruiting

1 location

Clinical Outcomes of Bilateral Clareon Vivity in Patients Af...

Correction Vision Surgery

Actively Recruiting

1 location

Comparing Efficacy of Bromfenac 0.09%, Nepafenac 0.3% and Di...

Macular Oedema

Actively Recruiting

1 location

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here